Median AFP-L3 (7% AFP-L3 fraction) and DCP (3.1 ng/mL) were both below the manufacturer-specified level for a positive test when utilized as an HCC surveillance assay (10% and 7.5 ng/mL, respectively). The gene discussed is AFP; the disease is hepatocellular carcinoma.